(Updated - April 5, 2022 5:51 AM EDT)

Barclays analyst Balaji Prasad initiates coverage on RVL Pharmaceuticals plc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE